浙富控股(002266.SZ)子公司簽署9483.5萬元示範快堆2號機組一體化擴散型氫計採購合同
格隆匯 6 月 30日丨浙富控股(002266.SZ)公佈,2020年6月30日,公司控股子公司四川華都核設備製造有限公司(“華都公司”)與中核龍原科技有限公司(“中核龍原”)簽署了《示範快堆2號機組一體化擴散型氫計採購合同》。
合同標的物:示範快堆2號機組一體化擴散型氫計項目設備,包括蒸發器出口鈉中氫計、蒸發器溢流管鈉中氫計、過熱器溢流管鈉中氫計及鈉緩衝罐氣中氫計等設備;合同價格:9483.5萬元。
在合同生效後,華都公司根據該工程的進度安排交付設備,具體交付進度根據合同約定時間履行。此次示範快堆2號機組設備金額約佔公司2019年度營業收入的8.75%,公司將按照交貨進度生產部件並確認銷售收入,預計將增加公司2020-2022年度的銷售收入和淨利潤。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.